Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more

: Verified by RoundPaper

FY 2024

Verified NonprofitLast Filed 2024EIN 82-2026061

Unemed Corporation

OMAHA, NENTEE: B11Founded 2016Website

mission statement

UNeMed Corporation's mission is to improve healthcare by fostering innovation, advancing biomedical research, and engaging entrepreneurs and industry to commercialize novel technologies.

Share this profile

Total Revenue

$3.8M

FY 2024

Program Spending

89.7%

of total expenses

Known Funders

institutional backers

Key Metrics (FY 2024)

The Numbers

$2.2M

Total Assets

$1.4M net

4.56 mo

Operating Reserves

FY 2024

+83%

Revenue Growth

YoY

Sector

NTEE B11

Programs (FY 2024)

What They Do

$3.4M in expenses

UNeMed Corporation is building and developing partnerships with industrial leaders to commercialize UNMC and UNO innovations.

Financial History

Revenue Over Time

Revenue Mix

Contributions & Grants

62%

Program Revenue

36%

Investment Income

Governance (FY 2024)

Leadership

Anne Barnes

Board Chair

Doug Ewald

Board Member

Rodney Markin

Board Member

Michael Dixon

Chief Executive Officer

Organization ExclusiveComing Soon

Your profile shows 0 known funders. We can find more.

Get a comprehensive Funder Intelligence Report with ranked prospects, fit scores, and funder briefs tailored to Unemed Corporation.

Ranked Funder Recommendations
AI Grant Proposal Blueprints
Funder Profiles with Giving Histories

Claim This Profile

Edit your mission, add context to sections, and control what funders see.

Earn your verified badge

Custom mission statement
Add a donate button
Show or hide sections
Add context notes for visitors

: Verified by RoundPaper

Verified NonprofitLast Filed 2024EIN 82-2026061

Unemed Corporation

OMAHA, NENTEE: B11Founded 2016

: Verified by RoundPaper

FY 2024

Verified NonprofitLast Filed 2024EIN 82-2026061

Unemed Corporation

OMAHA, NENTEE: B11Founded 2016Website

mission statement

UNeMed Corporation's mission is to improve healthcare by fostering innovation, advancing biomedical research, and engaging entrepreneurs and industry to commercialize novel technologies.

Share this profile

Total Revenue

$3.8M

FY 2024

Program Spending

89.7%

of total expenses

Known Funders

institutional backers

Key Metrics (FY 2024)

The Numbers

$2.2M

Total Assets

$1.4M net

4.56 mo

Operating Reserves

FY 2024

+83%

Revenue Growth

YoY

Sector

NTEE B11

Programs (FY 2024)

What They Do

$3.4M in expenses

UNeMed Corporation is building and developing partnerships with industrial leaders to commercialize UNMC and UNO innovations.

Financial History

Revenue Over Time

Revenue Mix

Contributions & Grants

62%

Program Revenue

36%

Investment Income

Governance (FY 2024)

Leadership

Anne Barnes

Board Chair

Doug Ewald

Board Member

Rodney Markin

Board Member

Michael Dixon

Chief Executive Officer

Organization ExclusiveComing Soon

Your profile shows 0 known funders. We can find more.

Get a comprehensive Funder Intelligence Report with ranked prospects, fit scores, and funder briefs tailored to Unemed Corporation.

Ranked Funder Recommendations
AI Grant Proposal Blueprints
Funder Profiles with Giving Histories

Claim This Profile

Edit your mission, add context to sections, and control what funders see.

Earn your verified badge

Custom mission statement
Add a donate button
Show or hide sections
Add context notes for visitors